Intersect ENT, Inc. is recalling 9,898 pouches of SINUVA (mometasone furoate) sinus implants (1350 mcg). The recall was issued because the implants failed to meet the required drug release rate (dissolution) at the nine-month stability check. No injuries or incidents have been reported in relation to this issue.
The drug may be released from the implant more slowly than intended, which could potentially impact the effectiveness of the treatment.
You have 2 options:
Rx Only; Manufactured by Intersect ENT, 1555 Adams Drive, Menlo Park, CA 94025.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.